CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 10 enrolled
Drug / intervention
Gallium Ga 68-labeled PSMA Ligand Glu-urea-Lys(Ahx) +3 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02488070
NCT02488070Phase 2Completed
CompareCT.gov

68Ga-PSMA PET/CT or PET/MRI in the Evaluation of Patients With Prostate Cancer: A Feasibility Study

Stanford University·interventional·Posted Jul 2, 2015·Updated Mar 20, 2018

In Brief

A Phase 2 clinical trial evaluating Computed Tomography, Gallium Ga 68-labeled PSMA Ligand Glu-urea-Lys(Ahx), and 2 other interventions for Recurrent Prostate Carcinoma. Completed, enrolled 10 participants across 1 site.

Detailed Summary

This clinical trial studies gallium-68 (68Ga)-prostate specific membrane antigen (PSMA) (gallium Ga 68-labeled PSMA ligand Glu-urea-Lys\[Ahx\]) positron emission tomography (PET)/computed tomography (CT) or PET/magnetic resonance imaging (MRI) in identifying prostate cancer that may have returned after a period of improvement (biochemical recurrence). 68Ga-PSMA is a radiopharmaceutical that localizes to a specific prostate cancer receptor, which can then be imaged by the PET/CT or PET/MRI scanner.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsRecurrent Prostate Carcinoma
CountriesUnited States
CollaboratorsNational Cancer Institute (NCI)

Timeline

Phase 2CompletedFinished
20162017201820192020202120222023202420252026
First PostedJul 2, 2015
Enrollment StartJun 1, 2015
Primary CompletionAug 1, 2015
Study CompletionAug 1, 2016
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 11 years ago

Interventions

Computed Tomographyprocedure

Part of PET/CT scan

Gallium Ga 68-labeled PSMA Ligand Glu-urea-Lys(Ahx)drug

Intravenously-administered (IV) radioisotope

Magnetic Resonance Imagingprocedure

Part of PET/MRI scan

Positron Emission Tomographyprocedure

Part of PET/CT and/or PET/MRI scans